BACKGROUND/OBJECTIVES: Cross-validation of methods of body composition assessment necessitates statistical evaluation of the degree to which the two methods are in agreement. Typically, impedance-based methods for predicting body composition are assessed against other methods using limits of agreement and correlation analysis. Alternative approaches are presented with reference to example body composition data obtained using bioimpedance spectroscopy (BIS) and dual-energy X-ray absorptiometry (DXA). SUBJECTS/METHODS: A randomly selected data set, drawn from a body composition database, was analysed by limits of agreement analysis and error grid analysis. RESULTS: The precision of BIS-derived predictions of percentage body fat relative to that of DXA can be determined from limits of agreement analysis. The importance of knowing the precision of the reference method in such analyses was highlighted. Error grid analysis has the potential to aid interpretation of method comparison data in an intuitively understandable way. CONCLUSIONS: Alternative ways of comparing analytical methods that are in use in other branches of biomedical research may prove useful when evaluating the utility of impedance-based methods and other methods for the assessment of body composition in cross-validation studies.
INTRODUCTION
There are many methods available for the assessment of body composition in vivo. [1] [2] [3] Each has its own particular strengths and weaknesses; some are considered criterion or reference methods, whereas others, although generally exhibiting lower accuracy, are used for their practicality and lower cost. 4 As a result, there is a need to validate these more commonly used methods, including bioelectrical impedance analysis, against reference methods such as the four-component model, or cross-validate them against a secondary standard such as dual-energy X-ray absorptiometry (DXA). Typically, the data from such studies are compared between methods by correlation and limits of agreement analysis. This latter method has achieved almost uniform acceptance as the definitive method for assessing agreement between methods of measurement, such that its use is mandated by some journals when reporting such studies. Nevertheless, alternatives are available that may be applicable to the assessment of the performance of techniques such as bioelectrical impedance analysis for the prediction of body composition.
LIMITS OF AGREEMENT ANALYSIS
In 1986, Bland and Altman published their seminal paper describing a statistical method for assessing the agreement between two methods of measurement of the same clinical variable. 5 Since then, the eponymously named Bland and Altman plot has become the accepted method for validating one method against another, preferably a reference method. The procedure assesses both the accuracy and precision of the method under test against the reference method assumed to be highly reliable and accurate, that is, measuring the true value of the parameter being measured. The measure of accuracy is the bias or difference between the two methods of measurement; the smaller the bias the higher the accuracy. The precision of the method is provided by the limits of agreement; the twice (actually 1.96 times) the standard deviation (s.d.) envelope either side of the bias that encompasses 95% of all data points. If the limits are narrow, the precision of the method is high. Ideally, a method should be both highly accurate and precise, that is, have a small bias and narrow limits of agreement. The wide acceptance of the Bland and Altman procedure is in large part due to the elegance of the representation of these statistical concepts in graphical form that are easily understood by non-statisticians.
Limits of agreement analysis is widely used in cross-validation studies of the impedance technique for assessing body composition. The impedance technique is frequently described (for example, Fors et al. 6 ) as having small bias but wide or 'relatively' wide limits of agreement, relative to what is often not defined. This is often interpreted as implying that the impedance method is eminently suitable for population-based studies (for example, Dehghan and Merchant 7 ), for example, in epidemiology, where the primary concern is to answer questions such as 'Do population X have different body composition from population Y' but less suitable for providing an accurate measurement of body composition for an individual in a population, as the limits of agreement are wide (for example, Isenring et al. ). However, the real value of a statistical procedure that assesses agreement between methods is whether to accept that the method under evaluation is acceptable as an alternative to the reference method. This necessitates defining a priori what limits of agreement are acceptable for the test method to have practical utility. The following analysis draws heavily upon the ideas proposed by Critchley and Critchley 9 and Cecconi et al. 10 who have done much to highlight how to interpret limits of agreement analysis in a clinical setting.
Critchley and Critchley, 9 when comparing the impedance and Doppler techniques for measuring cardiac output against the reference technique of intermittent thermodilution, proposed that the percentage error (PE) of the limits of agreement as compared with the mean could be used as a cut-off defining a threshold of acceptability. Furthermore, they suggested that for the new method (in their example impedance or Doppler) to be acceptable it should have accuracy and precision at least equal to that of the reference method (intermittent thermodilution). Cecconi et al. 10 take this argument further, stating that 'These concepts hold true for any study assessing a new methodology of measurement against a reference in clinical science'. This precept can be equally applied to assessing the acceptability of impedance methods for the assessment of body composition. This principle is tested here by comparing the assessment of percentage body fat by DXA with that determined by impedance. For the purpose of this paper, the DXA is assumed to be an acceptable reference technique.
WHOLE-BODY BIOELECTRICAL IMPEDANCE FOR THE ASSESSMENT OF BODY FAT PERCENTAGE: A COMPARISON WITH DXA USING LIMITS OF AGREEMENT ANALYSIS
Subject demographics and body composition data for 226 (101 M:125 F) subjects drawn from a database of body composition data maintained at the University of Queensland. Data were collected from a number of different studies of body composition in predominantly overweight and obese subjects. All subjects had whole-body (wrist to ankle) impedance measured with an SFB7 bioimpedance spectrometer (ImpediMed, Brisbane, Queensland, Australia). Impedance data were analysed using Cole modelling 11 with body composition predicted using Hanai mixture theory 12 with the software provided by the manufacturer (Bioimp v 4.12.0.0; ImpediMed). The majority of subjects (65%) were overweight or obese with a mean body mass index (BMI) of approximately 28.4 for both male and female individuals. The mean % body fat determined by DXA was 38.8% and 27.9% for female and male individuals, respectively, with an overall mean of 33.3%. The limits of agreement plot of these data is presented in Figure 1 . The bias between the two methods was 1.3% body fat, with limits of agreement of À 10.0 to 12.6% body fat. These data allow the calculation of the PE for the agreement between the techniques. The precision of a method is considered to be twice (1.96 times more precisely) the coefficient of variation (CV) for that technique. 10, 13 Thus, the precision for the DXA technique is given as follows:
and for bioimpedance spectroscopy (BIS) by
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The use of the data of Figure 1 yields a PE of ± 17%. In their consideration of the utility of impedance-based measurement of cardiac output, Critchley and Critchley 9 suggested that, as thermodilution has a precision of ± 20%, for impedance to be acceptable, an equal precision is required, that is, a PE of 28.3%. Since then, as noted by Cecconi et al., 10 this value has been rounded to 30% and used as an index of acceptability by many authors (for example, Stover et al.
14 and van der Kleij et al. 15 ). This principle can be applied to the present data but requires a measure of precision of the reference technique, DXA. Coefficients of variation for the DXA technique for measurement of % body fat have been determined in a number of studies (for example, Santos et al. 16 and Scafoglieri et al. 17 ) and ranges from around 1% to as high as almost 7%. [16] [17] [18] It is instructive to calculate a PE cutoff for acceptability of impedance-based measurements of % body fat based on these precision estimates for DXA.
The PE for the difference between DXA and BIS measurements, as well as being described by Equation 3, is equally described in terms of the CVs for each technique separately:
As PE DXA À BIS can be calculated from the Bland and Altman plot (above), the precision of the BIS technique can be calculated from the following equation:
On using the data above for the estimates of precision of the DXA technique and the PE of 17% for the data of Figure 1 , the precision of the BIS method varied from approximately 9.9 to 16.8%, with a mean of 14.9% for DXA CVs of 1, 7 and 4%. What conclusions can be drawn from this analysis? It is clear from Equation 6 that the limits of agreement clearly combine the imprecision of both methods under test. A given limit of agreement (or PE) can be obtained by different combinations of the individual precision errors of each technique. The interpretation of the limits of agreement therefore requires that the precision of the reference technique be known when deciding upon the acceptability of the new method. For the example data used here, if the data had been collected with a DXA that had a CV of 1%, then the performance of BIS is considerably worse than this and would be deemed unacceptable. In contrast, if the CV of the DXA measurements had been poor at 7%, then BIS measurements would have shown comparable precision and be deemed acceptable.
Cecconi et al. 10 have provided recommendations for validation studies of cardiac monitors that are equally applicable when assessing the validity of impedance analysis:
(a) the reference technique should be as accurate and precise as possible; (b) the precision of the reference technique should be measured within the study; (c) the desired precision of the test method should be stated a priori; (d) the bias and limits of agreement should be quoted and (e) the precision of the test method should be calculated.
Adoption of these principles would address concerns raised by Parker et al. 19 that many validation studies of methods for body composition analysis have simply compared non-reference methods of unknown validity (that is, unknown precision) against other methods of unknown validity. They further point out that such studies, although common, do not establish the validity of a test method. Those researchers engaged in evaluating the impedance technique would do well to follow the recommendations listed above.
ERROR GRID ANALYSIS
Assessment of the method performance is a prerequisite in many aspects of clinical medicine. Clinical chemistry has taken a lead in establishing standardised procedures for quality control of assay methods. 20 Various assessment criteria have been proposed, and the one that is well known for the evaluation of glucose assays is error grids. 21 An error grid is a graphical representation of quantitative data measured in the same units obtained by two different methods, the test and comparative or reference method. Introduced originally by Clarke et al. 22 the error grid is a familiar correlation plot with the data points plotted with the reference technique as the abscissa and the test method as the ordinate axes along with the diagonal line of identity. Data points falling above the line represent overestimates by the test method and those that fall below represent underestimates. Overlaying this is a pattern of grids defining zones of varying degrees of accuracy and inaccuracy of measurement of blood glucose concentrations. The performance of a test method for glucose estimation is then assessed on the proportions of data that fall in the different zones: a zone of allowable error on either side of the line of identity, which should contain most (95%) of the data points, an intermediate zone, which should contain o5% of the data points, and an outer zone, where the amount of error is unacceptable and should ideally contain no data points. The key to this approach is in defining the concentrations of glucose that delineate the different zones. In the case of glucose estimations, these are based upon current clinical practice that invokes intervention to adjust blood glucose concentration when it falls outside clinically accepted ranges. Krouwer et al. 23 have proposed that this approach can be used for other diagnostic assays with the aim of answering the question of a test method 'is the estimated performance 'good enough'?' An adaptation of this approach to the assessment of performance of the impedance technique for estimation of % body fat is explored below using the same data as in the previous section.
WHOLE-BODY BIOELECTRICAL IMPEDANCE FOR THE ASSESSMENT OF BODY FAT PERCENTAGE: A COMPARISON WITH DXA USING ERROR GRID ANALYSIS
The use of impedance analysis of body composition is commonly to determine the relative amounts of body fat and non-fat tissue, the fat-free mass. The practical use to which this information is put is varied, but it is often used as a guide, for example, in weight management. Frequently, the precise amount of body fat and fatfree mass in an individual are of less relevance clinically than whether the individual falls within a specified healthy or unhealthy range. This is typified by the widespread use of BMI as a surrogate measure of body adiposity. Typically, an individual's BMI value is simply used to stratify them to a BMI band. For example, the World Health Organisation classes those with a BMI of o18.5 kg/m 2 as underweight; those with a BMI of 18. 24 with these bands relating to health risk. Less commonly, BMI values may be converted directly to % body fat. The approach taken here was to combine the utility of the simple BMI-based classification with error grid analysis based on % body fat values measured by DXA and impedance. Figure 2 presents a scatter plot of the % body fat measured by BIS and DXA for the individuals described in Table 1 . The diagonal dotted line represents the line of identity. Grid lines define regions bounded by % body fat values for BMI classification thresholds. The conversion of BMI to % body fat, as measured by bioelectrical impedance, used the regression equations published by Meeuwsen et al. 25 for a large (n ¼ 23627) cross-sectional sample of the population of the United Kingdom. This study demonstrated that the relationship between BMI and % body fat is curvilinear and influenced by age and sex. For the purpose of the present analysis, the grid lines represent the estimated % body fat for 45-year-old women. Alternative grids could be constructed for other age groups and for male individuals.
The majority of participants fall close to the line of identity and outside the error grids. Five female individuals (4% of all females), circled in Figure 2 , fall either within a grid or on a boundary between grids. Alternatively stated, 96% of participants fall within the region of acceptable error. One of the participants, marked by the arrow in Figure 2 , serves to illustrate additional information that may be gleaned from this type of analysis. This individual has a % body fat as measured by DXA of 50.2% but a BIS estimate of 37.0%. This individual on the basis of DXA % body fat would therefore be classed as obese class III on the World Health Organisation BMI classification but only overweight or pre-obese on the basis of BIS estimates of % body fat. As the World Health Organisation BMI cut-offs may be used to instigate health interventions, an appreciation of the likelihood that individuals may be misclassified by a measurement technique is likely to have clinical utility. In this example, % body fat data have been interpreted with reference to BMI despite the widely acknowledged problems associated with the use of BMI as a measure of Figure 2 . Correlation of % body fat measured by DXA and predicted by BIS. K Males; m Females; ---Line of identity. Circles highlight female participants whose data falls within grids, bounded by boxes, defining regions of % body fat corresponding to BMI cut-offs set by the World Health Organisation. 24, 25 The arrow identifies participant discussed in text.
adiposity. 26, 27 Irrespective of these problems, the example serves to illustrate the potential that error grids may provide when considering the comparative performance of bioelectrical impedance-derived body composition estimates with those of other methods.
CONCLUDING REMARKS
The aim of this paper was to draw upon approaches used in other branches of biomedical research that may be of value in validation studies in body composition research and of bioimpedance methodology in particular. An appreciation of the importance of the precision of not only the impedance method but also of the reference technique against which it is being compared is crucial; if the reference method has poor precision, we may be misled in our assessment of the performance of impedance analysis. The Bland and Altman method applied to the example data here suggests that BIS is less precise than DXA when predicting % body fat. However, when viewing these data through the lens of one of the most commonly used tools to assess body adiposity, BMI, it appears to perform creditably. Considering the data in this way may be useful to the clinician or public health nutritionist when evaluating interventions based on body composition data obtained using more than one measurement technique. The examples used here should not be considered as definitive or mandatory approaches to be used in this context. The hope is that they will stimulate a broader view of how we interpret data from such studies.
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